UnknownNot Applicable

Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome

100 participantsStarted 2024-04

Plain-language summary

This is a randomized controlled study, including dysphagic patients with Parkinson's syndrome who were received in the department of rehabilitation medicine. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, Functional Oral Intake Scale, Drooling amount, depression are assessed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 years. * Meeting the diagnostic criteria for Parkinson's disease developed by the Neurology Branch of the Chinese Medical Association in 2006. * Diagnosed with dysphagia confirmed by the video fluoroscopic swallowing study. * Stable vital signs, conscious, able to cooperate with assessment and treatment. Exclusion Criteria: * Dysphagia possibly caused by other reasons, such as cerebrovascular disease, trauma, neuromuscular diseases, malignant diseases of the pharynx and larynx, and digestive tract diseases. * History of mental diseases or use of antipsychotics. * Complicated with cognitive impairment or consciousness dysfunction. * Simultaneously suffering from severe liver, kidney failure, tumors, or hematological diseases.

What they're measuring

Drooling amount

Timeframe: day 1 and day 10

Trial details

NCT IDNCT06370195

SponsorBabujinaya Cela

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Laviena Ce

15422548954 linchuangzhuce@126.com

View on ClinicalTrials.gov More Parkinson's Syndrome trials